Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Current Alzheimer Research|July 11, 2015
Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's DiseaseAnn-Marie Waldron, Leonie Wyffels, Jeroen Verhaeghe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2017
Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer DiseaseSteven Deleye, Ann-Marie Waldron, Jeroen Verhaeghe, et al.
Journal of Alzheimer'S Disease : JAD|March 27, 2023
Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal FluidDina Rodrigues Martins, Marc Vandermeeren, Kristof Van Kolen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 11, 2008
Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degenerationLeen Hulshagen, Olga Krysko, Astrid Bottelbergs, et al.
Scientific Reports|November 10, 2019
Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer's disease pathologySofia Jacob, Gethin Davies, Marijke De Bock, et al.
Frontiers in Aging Neuroscience|October 9, 2024
NLRP3 inflammasome activation and pyroptosis are dispensable for tau pathologyIne Paesmans, Kristof Van Kolen, Marc Vandermeeren, et al.
Molecular Imaging|April 1, 2016
Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807Lieven Declercq, Sofie Celen, Joan Lecina, et al.
Neurobiology of Disease|June 20, 2013
Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulationSimon Verheijden, Astrid Bottelbergs, Olga Krysko, et al.
Acta Neuropathologica Communications|June 9, 2021
CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microgliaChritica Lodder, Isabelle Scheyltjens, Ilie Cosmin Stancu, et al.
Neurobiology of Disease|April 13, 2021
Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing miceJonathan Janssens, Bart Hermans, Marc Vandermeeren, et al.
Pageof 4